{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:08:48Z","timestamp":1791875328456,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.neuropharm.2016.12.005","type":"journal-article","created":{"date-parts":[[2016,12,9]],"date-time":"2016-12-09T20:40:29Z","timestamp":1481316029000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Active vaccination attenuates the psychostimulant effects of \u03b1-PVP and MDPV in rats"],"prefix":"10.1016","volume":"116","author":[{"given":"Jacques D.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul T.","family":"Bremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Ducime","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Creehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2421-1190","authenticated-orcid":false,"given":"Brent R.","family":"Kisby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9827-1738","authenticated-orcid":false,"given":"Michael A.","family":"Taffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim D.","family":"Janda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.neuropharm.2016.12.005_bib1","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1007\/s00213-015-3944-8","article-title":"In\u00a0vivo potency and efficacy of the novel cathinone alpha-pyrrolidinopentiophenone and 3,4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male rats","volume":"232","author":"Aarde","year":"2015","journal-title":"Psychopharmacol. (Berl)"},{"key":"10.1016\/j.neuropharm.2016.12.005_bib2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neuropharm.2013.04.003","article-title":"The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: self-administration and locomotor activity in rats","volume":"71","author":"Aarde","year":"2013","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/j.neuropharm.2016.12.005_bib3","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1007\/s00213-014-3819-4","article-title":"Binge-like acquisition of 3,4-methylenedioxypyrovalerone (MDPV) self-administration and wheel activity in rats","volume":"232","author":"Aarde","year":"2015","journal-title":"Psychopharmacol. (Berl)"},{"key":"10.1016\/j.neuropharm.2016.12.005_bib4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.aca.2014.04.015","article-title":"3,4-Methylenedioxypyrovalerone (MDPV) and metabolites quantification in human and rat plasma by liquid chromatography-high resolution mass spectrometry","volume":"827","author":"Anizan","year":"2014","journal-title":"Anal. Chim. Acta"},{"issue":"4","key":"10.1016\/j.neuropharm.2016.12.005_bib5","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/npp.2012.204","article-title":"Powerful cocaine-like actions of 3,4-Methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products","volume":"38","author":"Baumann","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"19","key":"10.1016\/j.neuropharm.2016.12.005_bib6","first-page":"624","article-title":"Emergency department visits after use of a drug sold as \u201cbath salts\u201d \u2013- Michigan, november 13, 2010\u2013march 31, 2011","volume":"60","author":"Benzie","year":"2011","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"3","key":"10.1016\/j.neuropharm.2016.12.005_bib7","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1021\/mp400631w","article-title":"Injection route and TLR9 agonist addition significantly impact heroin vaccine efficacy","volume":"11","author":"Bremer","year":"2014","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.neuropharm.2016.12.005_bib8","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.bmc.2003.11.029","article-title":"Investigations using immunization to attenuate the psychoactive effects of nicotine","volume":"12","author":"Carrera","year":"2004","journal-title":"Bioorg Med. Chem."},{"issue":"6558","key":"10.1016\/j.neuropharm.2016.12.005_bib9","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/378727a0","article-title":"Suppression of psychoactive effects of cocaine by active immunization","volume":"378","author":"Carrera","year":"1995","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.neuropharm.2016.12.005_bib10","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1021\/bc500016k","article-title":"Investigating hapten clustering as a strategy to enhance vaccines against drugs of abuse","volume":"25","author":"Collins","year":"2014","journal-title":"Bioconjug Chem."},{"issue":"204","key":"10.1016\/j.neuropharm.2016.12.005_bib11","first-page":"65371","article-title":"Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Final Order","volume":"76","author":"Drug Enforcement Administration DoJ","year":"2011","journal-title":"Fed. Regist."},{"issue":"45","key":"10.1016\/j.neuropharm.2016.12.005_bib12","first-page":"12938","article-title":"Schedules of controlled substances: temporary placement of 10 synthetic cathinones into Schedule I. Final order","volume":"79","author":"Drug Enforcement Administration DoJ","year":"2014","journal-title":"Fed. Regist."},{"issue":"22","key":"10.1016\/j.neuropharm.2016.12.005_bib13","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1016\/j.vaccine.2009.02.105","article-title":"Immune responses to methamphetamine by active immunization with peptide-based, molecular adjuvant-containing vaccines","volume":"27","author":"Duryee","year":"2009","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.neuropharm.2016.12.005_bib14","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/npp.2012.233","article-title":"In\u00a0vivo effects of abused 'bath salt' constituent 3,4-methylenedioxypyrovalerone (MDPV) in mice: drug discrimination, thermoregulation, and locomotor activity","volume":"38","author":"Fantegrossi","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2016.12.005_bib15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1124\/jpet.115.223586","article-title":"Comparative behavioral pharmacology of three pyrrolidine-containing synthetic cathinone derivatives","volume":"354","author":"Gatch","year":"2015","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"issue":"5\u20136","key":"10.1016\/j.neuropharm.2016.12.005_bib16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/FBP.0b013e328364166d","article-title":"Locomotor stimulant and discriminative stimulus effects of 'bath salt' cathinones","volume":"24","author":"Gatch","year":"2013","journal-title":"Behav. Pharmacol."},{"issue":"4","key":"10.1016\/j.neuropharm.2016.12.005_bib17","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4161\/hv.5.4.7456","article-title":"Development of active and passive human vaccines to treat methamphetamine addiction","volume":"5","author":"Gentry","year":"2009","journal-title":"Hum. Vaccin"},{"issue":"3","key":"10.1016\/j.neuropharm.2016.12.005_bib18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pbb.2011.05.006","article-title":"Influences of activity wheel access on the body temperature response to MDMA and methamphetamine","volume":"99","author":"Gilpin","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2016.12.005_bib19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/B978-0-12-420118-7.00015-9","article-title":"Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention","volume":"69","author":"Glennon","year":"2014","journal-title":"Adv. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2016.12.005_bib20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.drugalcdep.2012.05.011","article-title":"Contrasting effects of d-methamphetamine, 3,4-methylenedioxymethamphetamine, 3,4-methylenedioxypyrovalerone, and 4-methylmethcathinone on wheel activity in rats","volume":"126","author":"Huang","year":"2012","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.neuropharm.2016.12.005_bib21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s002130050049","article-title":"Evaluation of anti-cocaine antibodies and a cocaine vaccine in a rat self-administration model","volume":"148","author":"Kantak","year":"2000","journal-title":"Psychopharmacol. (Berl)"},{"issue":"6","key":"10.1016\/j.neuropharm.2016.12.005_bib22","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1521-0391.2014.12152.x","article-title":"Attenuation of cocaine-induced locomotor activity in male and female mice by active immunization","volume":"23","author":"Kosten","year":"2014","journal-title":"Am. J. Addict."},{"issue":"3\u20134","key":"10.1016\/j.neuropharm.2016.12.005_bib23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00213-005-0027-2","article-title":"Effects of a nicotine conjugate vaccine on the acquisition and maintenance of nicotine self-administration in rats","volume":"184","author":"LeSage","year":"2006","journal-title":"Psychopharmacol. (Berl)"},{"key":"10.1016\/j.neuropharm.2016.12.005_bib24","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neuropharm.2014.02.016","article-title":"Pharmacology of novel synthetic stimulants structurally related to the \u201cbath salts\u201d constituent 3,4-methylenedioxypyrovalerone (MDPV)","volume":"87","author":"Marusich","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2016.12.005_bib25","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.drugalcdep.2015.06.014","article-title":"Effects of active anti-methamphetamine vaccination on intravenous self-administration in rats","volume":"153","author":"Miller","year":"2015","journal-title":"Drug Alcohol Depend."},{"issue":"8","key":"10.1016\/j.neuropharm.2016.12.005_bib26","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.biopsych.2012.09.010","article-title":"A\u00a0methamphetamine vaccine attenuates methamphetamine-induced disruptions in thermoregulation and activity in rats","volume":"73","author":"Miller","year":"2013","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.neuropharm.2016.12.005_bib27","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1021\/mp900213u","article-title":"A\u00a0critical evaluation of a nicotine vaccine within a self-administration behavioral model","volume":"7","author":"Moreno","year":"2010","journal-title":"Mol. Pharm."},{"issue":"12","key":"10.1016\/j.neuropharm.2016.12.005_bib28","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1586\/erv.11.145","article-title":"Current challenges for the creation of effective vaccines against drugs of abuse","volume":"10","author":"Moreno","year":"2011","journal-title":"Expert Rev. vaccines"},{"key":"10.1016\/j.neuropharm.2016.12.005_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12398","article-title":"Escalation of intravenous self-administration of methylone and mephedrone under extended access conditions","author":"Nguyen","year":"2016","journal-title":"Addict. Biol."},{"issue":"1","key":"10.1016\/j.neuropharm.2016.12.005_bib30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0091-3057(99)00206-3","article-title":"A\u00a0nicotine conjugate vaccine reduces nicotine distribution to brain and attenuates its behavioral and cardiovascular effects in rats","volume":"65","author":"Pentel","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"7","key":"10.1016\/j.neuropharm.2016.12.005_bib31","doi-asserted-by":"crossref","first-page":"e101807","DOI":"10.1371\/journal.pone.0101807","article-title":"Effects of an oxycodone conjugate vaccine on oxycodone self-administration and oxycodone-induced brain gene expression in rats","volume":"9","author":"Pravetoni","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.neuropharm.2016.12.005_bib32","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1124\/jpet.107.135111","article-title":"Combined active and passive immunization enhances the efficacy of immunotherapy against nicotine in rats","volume":"325","author":"Roiko","year":"2008","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"issue":"10","key":"10.1016\/j.neuropharm.2016.12.005_bib33","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s00213-015-4057-0","article-title":"Reinforcing and neurochemical effects of the \u201cbath salts\u201d constituents 3,4-methylenedioxypyrovalerone (MDPV) and 3,4-methylenedioxy-N-methylcathinone (methylone) in male rats","volume":"233","author":"Schindler","year":"2016","journal-title":"Psychopharmacol. (Berl)"},{"issue":"22","key":"10.1016\/j.neuropharm.2016.12.005_bib34","doi-asserted-by":"crossref","first-page":"9036","DOI":"10.1073\/pnas.1219159110","article-title":"Dynamic vaccine blocks relapse to compulsive intake of heroin","volume":"110","author":"Schlosburg","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2016.12.005_bib35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.drugalcdep.2012.09.007","article-title":"A\u00a0vaccine against methamphetamine attenuates its behavioral effects in mice","volume":"129","author":"Shen","year":"2013","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.neuropharm.2016.12.005_bib36","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1476-5381.2012.02145.x","article-title":"Pharmacological characterization of designer cathinones in\u00a0vitro","volume":"168","author":"Simmler","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2016.12.005_bib37","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1369-1600.2012.00474.x","article-title":"Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV)","volume":"19","author":"Watterson","year":"2014","journal-title":"Addict. Biol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390816305603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390816305603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T23:25:35Z","timestamp":1536189935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390816305603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":37,"alternative-id":["S0028390816305603"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.12.005","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Active vaccination attenuates the psychostimulant effects of \u03b1-PVP and MDPV in rats","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2016.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}